Company Filing History:
Years Active: 2013-2023
Title: Christina Fleet: Innovator in Monoclonal Antibodies
Introduction
Christina Fleet is a prominent inventor based in Melrose, MA (US). She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 5 patents to her name, her work focuses on innovative treatments for cell proliferative diseases.
Latest Patents
Among her latest patents are the Anti-ErbB3 antibodies. These monoclonal antibodies are designed to bind and inhibit the activation of the epidermal growth factor receptor-related member ErbB3/HER3. The implications of her work are profound, as these antibodies can be utilized to treat various forms of cancer associated with the activation of ErbB3/HER3.
Career Highlights
Christina Fleet is currently associated with Aveo Pharmaceuticals, Inc., where she continues to advance her research and development efforts. Her expertise in monoclonal antibodies has positioned her as a key player in the biotechnology sector.
Collaborations
Some of her notable coworkers include Sylvie Vincent and William M Winston, Jr. Their collaborative efforts contribute to the innovative environment at Aveo Pharmaceuticals, Inc.
Conclusion
Christina Fleet's work in the field of monoclonal antibodies represents a significant advancement in the treatment of cancer and other cell proliferative diseases. Her contributions are paving the way for future innovations in biotechnology.